| Title |
A 26 + 26-week, randomized, open, parallel controlled, multicenter clinical study comparing the efficacy and safety of INS068 injection and insulin glargine combined with oral hypoglycemic agents in patients with type 2 diabetes mellitus who were newly treated with insulin |
| Description |
This project is a randomized, open, parallel controlled, multicenter clinical study aimed at comparing the efficacy and safety of INS068 injection and insulin glargine combined with oral hypoglycemic drugs in patients with type 2 diabetes mellitus newly treated with insulin. It is expected to be submitted to FDA in September for post-phase 2 communication |
| Organism |
Homo sapiens |
| Data Type |
Other Type of Metabolome Data |
| Data Accessibility |
Controlled-access |
| BioProject |
PRJCA011393 |
| Release Date |
2024-08-23 |
| Submitter |
miao wang (miao.wang.mw5@hengrui.com) |
| Organization |
Jiangsu Hengrui Pharmaceutical Co., Ltd |
| Submission Date |
2022-08-23 |